210 related articles for article (PubMed ID: 27838288)
1. Intra-articular injection of Botulinum toxin A reduces neurogenic inflammation in CFA-induced arthritic rat model.
Wang L; Wang K; Chu X; Li T; Shen N; Fan C; Niu Z; Zhang X; Hu L
Toxicon; 2017 Feb; 126():70-78. PubMed ID: 27838288
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of botulinum toxin type a in a complete Freund's adjuvant-induced arthritic knee joint of hind leg on rat model.
Yoo KY; Lee HS; Cho YK; Lim YS; Kim YS; Koo JH; Yoon SJ; Lee JH; Jang KH; Song SH
Neurotox Res; 2014 Jul; 26(1):32-9. PubMed ID: 24338136
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of botulinum toxin type A on the microglial P2X7/CatS/FKN activated-pathway in antigen-induced arthritis of the temporomandibular joint of rats.
Manuel Muñoz-Lora VR; Abdalla HB; Del Bel Cury AA; Clemente-Napimoga JT
Toxicon; 2020 Nov; 187():116-121. PubMed ID: 32882256
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type A reduces inflammatory hypernociception induced by arthritis in the temporomadibular joint of rats.
Lora VR; Clemente-Napimoga JT; Abdalla HB; Macedo CG; Canales GT; Barbosa CM
Toxicon; 2017 Apr; 129():52-57. PubMed ID: 28209481
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling.
Shi X; Gao C; Wang L; Chu X; Shi Q; Yang H; Li T
Toxicon; 2020 Apr; 178():33-40. PubMed ID: 32250746
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain.
Mahowald ML; Krug HE; Singh JA; Dykstra D
Toxicon; 2009 Oct; 54(5):658-67. PubMed ID: 19351542
[TBL] [Abstract][Full Text] [Related]
7. Long term effects of intra-articular botulinum toxin A for refractory joint pain.
Mahowald ML; Singh JA; Dykstra D
Neurotox Res; 2006 Apr; 9(2-3):179-88. PubMed ID: 16785116
[TBL] [Abstract][Full Text] [Related]
8. The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model.
Reducha PV; Bömers JP; Edvinsson L; Haanes KA
Headache; 2024 Jun; 64(6):652-662. PubMed ID: 38700141
[TBL] [Abstract][Full Text] [Related]
9. Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis.
Lu Y; McNearney TA; Wilson SP; Yeomans DC; Westlund KN
Eur J Neurosci; 2008 Mar; 27(5):1153-65. PubMed ID: 18364035
[TBL] [Abstract][Full Text] [Related]
10. Blockade of spinal glutamate recycling produces paradoxical antinociception in rats with orofacial inflammatory pain.
Yang KY; Mun JH; Park KD; Kim MJ; Ju JS; Kim ST; Bae YC; Ahn DK
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():100-9. PubMed ID: 25445477
[TBL] [Abstract][Full Text] [Related]
11. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
[TBL] [Abstract][Full Text] [Related]
12. The effect of intra-articular botulinum toxin A on substance P, prostaglandin E
Heikkilä HM; Hielm-Björkman AK; Innes JF; Laitinen-Vapaavuori OM
BMC Vet Res; 2017 Mar; 13(1):74. PubMed ID: 28327134
[TBL] [Abstract][Full Text] [Related]
13. Experimental model of temporomandibular joint arthritis: Evaluation of contralateral joint and masticatory muscles.
Lemos GA; da Silva PLP; Batista AUD; Palomari ET
Arch Oral Biol; 2018 Nov; 95():79-88. PubMed ID: 30071410
[TBL] [Abstract][Full Text] [Related]
14. Evidence for neurogenic transmission inducing degenerative cartilage damage distant from local inflammation.
Decaris E; Guingamp C; Chat M; Philippe L; Grillasca JP; Abid A; Minn A; Gillet P; Netter P; Terlain B
Arthritis Rheum; 1999 Sep; 42(9):1951-60. PubMed ID: 10513812
[TBL] [Abstract][Full Text] [Related]
15. Anti-Inflammatory Effects of BoNT/A Against Complete Freund's Adjuvant-Induced Arthritis Pain in Rats: Transcriptome Analysis.
Li X; Ye Y; Zhou W; Shi Q; Wang L; Li T
Front Pharmacol; 2021; 12():735075. PubMed ID: 34803684
[TBL] [Abstract][Full Text] [Related]
16. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A reduces TRPV1 expression in the dorsal root ganglion in rats with adjuvant-arthritis pain.
Fan C; Chu X; Wang L; Shi H; Li T
Toxicon; 2017 Jul; 133():116-122. PubMed ID: 28478059
[TBL] [Abstract][Full Text] [Related]
18. Analgesic effect of the neuropeptide cortistatin in murine models of arthritic inflammatory pain.
Morell M; Souza-Moreira L; Caro M; O'Valle F; Forte-Lago I; de Lecea L; Gonzalez-Rey E; Delgado M
Arthritis Rheum; 2013 May; 65(5):1390-401. PubMed ID: 23371349
[TBL] [Abstract][Full Text] [Related]
19. Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis pain.
Anderson S; Krug H; Dorman C; McGarraugh P; Frizelle S; Mahowald M
J Pain Res; 2010 Sep; 3():161-8. PubMed ID: 21197320
[TBL] [Abstract][Full Text] [Related]
20. Antihyperalgesic effect of systemic dexmedetomidine and gabapentin in a rat model of monoarthritis.
Zhang WS; Xu H; Xu B; Sun S; Deng XM; Zhang YQ
Brain Res; 2009 Apr; 1264():57-66. PubMed ID: 19368840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
